NCT05038605

Brief Summary

While some investigators found oral metronidazole to be effective in reducing pain after hemorrhoidectomy, other researchers did not find a significant analgesic effect of systemic metronidazole. On the other hand, topical application of metronidazole had more consistent favorable results as Ala et al documented a remarkable analgesic effect of topical metronidazole 10% after excisional hemorrhoidectomy which was in line with Nicholson and Armestrong who also concluded similar results. No previous study compared the analgesic effect of topical and oral metronidazole after anorectal surgery. Therefore, the present trial was conducted to compare the impact of oral versus systemic metronidazole on pain and recovery after surgery for benign anorectal conditions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
108

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 24, 2020

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2021

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

August 29, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

September 9, 2021

Completed
Last Updated

September 9, 2021

Status Verified

August 1, 2021

Enrollment Period

1 year

First QC Date

August 29, 2021

Last Update Submit

August 31, 2021

Conditions

Outcome Measures

Primary Outcomes (3)

  • Postoperative pain score

    Pain was assessed using visual analogue scale form 0 to 10, higher score indicates worse pain

    at one day after surgery

  • Postoperative pain score

    Pain was assessed using visual analogue scale form 0 to 10, higher score indicates worse pain

    at two days after surgery

  • Postoperative pain score

    Pain was assessed using visual analogue scale form 0 to 10, higher score indicates worse pain

    at seven days after surgery

Study Arms (3)

Topical metronidazole

ACTIVE COMPARATOR

Topical application of metronidazole cream on the anal verge after surgery

Drug: Topical metronidazole

Oral metronidazole

ACTIVE COMPARATOR

oral metronidazole 500 mg tablets after surgery

Drug: oral metronidazole

Control

NO INTERVENTION

No metronidazole was received

Interventions

Topical application of metronidazole cream on the anal verge every 8 hours after surgery

Topical metronidazole

Patients received oral metronidazole 500 mg tablets every 8 hours after surgery

Oral metronidazole

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients of either sex aged below 70 years
  • Underwent surgery for hemorrhoids, anal fissure, or simple anal fistula.

You may not qualify if:

  • Grade I-II hemorrhoids.
  • acute anal fissure.
  • complex anal fistula
  • perianal abscess
  • perianal Crohn's disease
  • malignancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mansoura university hospital

Al Mansurah, Dakahlia Governorate, 35516, Egypt

Location

MeSH Terms

Conditions

HemorrhoidsFissure in AnoRectal Fistula

Interventions

Metronidazole

Condition Hierarchy (Ancestors)

Rectal DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System DiseasesVascular DiseasesCardiovascular DiseasesAnus DiseasesIntestinal FistulaDigestive System FistulaFistulaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

NitroimidazolesNitro CompoundsOrganic ChemicalsImidazolesAzolesHeterocyclic Compounds, 1-RingHeterocyclic Compounds

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor of surgery

Study Record Dates

First Submitted

August 29, 2021

First Posted

September 9, 2021

Study Start

January 24, 2020

Primary Completion

January 30, 2021

Study Completion

March 1, 2021

Last Updated

September 9, 2021

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will not share

Locations